Analysis: Drug makers vulnerable if health law revoked

Published Updated 6 Min Read

IMGCAP(1)]

Thu., May 24, 2012 LOS ANGELES (Reuters) — Pharmaceutical companies, which were spared some of the more sweeping regulations in President Barack Obama’s health care overhaul, could come under more pressure if the U.S. Supreme Court strikes down part or all of the 2010 law.


For reprint and licensing requests for this article, click here.


More From Employee Benefit News

Sign Up Form

Login Modal Form